Home » About Us » Our Team » Abhay Moghekar, M.D.

Abhay Moghekar, M.D.

Clinical Core Co-Leader
Biomarker Core: Co-Leader
E-mail: [email protected]

Dr. Moghekar is an Associate Professor of Neurology. His research interests pertain to biomarkers in cerebrospinal fluid (CSF). He is examining standard Alzheimer’s disease CSF biomarkers in a range of subject populations and conducting studies to identify novel CSF biomarkers.


  • Kamalian A, Ho S, Patel M, Lewis A, Bakker A, Albert M, O’Brien R, Moghekar A, Lutz M. Exploratory assessment of proteomic network changes in cerebrospinal fluid of mild cognitive impairment patients: A pilot study. Biomolecules, 2023; 13: 1094.
  • Greenberg B, Pettigrew C, Soldan A, Wang J, Wang M-C, Darrow J, Albert M, Moghekar A. CSF Alzheimer’s disease biomarkers: Time-varying relationships with MCI symptom onset, and associations with age, sex and ApoE4. Neurology, 2022; 99: e1640-e1650.
  • Sathe G, Albert M, Darrow J, Saito A, Troncoso J, Pandey A, Moghekar A. Quantitative proteomic analysis of the frontal cortex in Alzheimer’s disease. J Neurochem. 2021;156:988-1002.
  • Sathe G, Na C, Renuse S, Madugundu A, Albert M, Moghekar A, Pandey A. Phosphotyrosine profiling of human cerebrospinal fluid. Clinical Proteomics 2018, 15:29.
  • Moghekar A, Li S, Lu Y, Li M, Wang MC, Albert M, O’Brien R. CSF biomarker changes precede symptom onset of mild cognitive impairment. Neurology.2013; 81: 1753-1758.


Primary Appointment in Neurology